Connect with us

Hi, what are you looking for?

Monday, Sep 26, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

Health Canada forming a committee to regulate non-prescription weed products

The department is seeking nominations for a committee to help develop safety and evidence standards

Cannabis companies must be 'financially viable' before COVID-19 to get federal relief funds
Cannabis companies must be 'financially viable' before COVID-19 to get federal relief funds

Health Canada is forming a committee of scientists to help it navigate the emerging world of non-prescription health products containing weed. 

The Science Advisory Committee for Health Products Containing Cannabis will provide independent scientific and evidence-based advice as Health Canada works out safety and evidence standards for these new products, the department announced Thursday. 

Read more: Health Canada wants to ban advertising of vapes to deter youth

Read more: Metro Vancouver poised to draft controversial cannabis emissions bylaws 

This will include reviewing evidence of how weed can be used as a health product, reviewing emerging clinical studies and suggesting safety standards for health products, such as dosage, quality and efficacy.

Health Canada is also creating a sub-committee to address issues related to cannabis products for animals. 

The department is seeking eight to 12 committee members form a wide range of knowledge and experience, including Canadians with lived experience as medical cannabis patients.

Committee members can be nominated by others or themselves and will be selected by federal government staff. 

Issues the committee might be asked to tackle include using THC or CBD for therapeutic purposes, how to tackle gaps in a doctor’s knowledge about cannabis and what harms using THC or CBD could pose when being used without a doctor’s advice. 

The idea to form a committee was created during Health Canada’s consultations, which ran from June 19, 2019, to Sept. 3, 2019, in which the department asked how it should approach regulating non-prescription health products. 

Top image of the Peace Tower in Ottawa via Deposit Photos

 

michelle@mugglehead.com

@missmishelle

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Canada

Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic

News

Meditation helps reduce the heartrate by engaging the parasympathetic nervous system and slowing breathing, which increases sleep quality.

Canada

Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada

Canada

Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies